Acute Coronary Syndromes. Don't Bypass the Clopidogrel

Journal of the American College of Cardiology

Volumn 53, Issue 21, 2009, Pages 1973-1974

  Barker, Colin M ^a   Anderson, H Vernon ^b  

^a SCRIPPS CLINIC   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

acute coronary syndromes; clopidogrel; coronary artery bypass surgery

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST;

ACUTE CORONARY SYNDROME; BLEEDING; CARDIOVASCULAR RISK; CLINICAL RESEARCH; CORONARY ARTERY BYPASS SURGERY; DRUG EFFICACY; DRUG WITHDRAWAL; EDITORIAL; HEART INFARCTION; HOSPITALIZATION; HUMAN; INDIVIDUALIZATION; MEDICAL LITERATURE; PRIORITY JOURNAL; REVASCULARIZATION; ST SEGMENT ELEVATION; STROKE;

ACUTE CORONARY SYNDROME; CORONARY ARTERY BYPASS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; PLATELET AGGREGATION INHIBITORS; PREOPERATIVE CARE; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 65549108755     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.02.029     Document Type: Editorial

References (10)

1. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., and Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST segment elevation. N Engl J Med 345 (2001) 495-502
2. Yusuf S., Mehta S.R., Zhao F., et al. Early and late effects of clopidogrel in patients with acute coronary syndromes. Circulation 107 (2003) 966-972
3. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, American College of Physicians, Society for Academic Emergency Medicine, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 50 (2007) e1-e157
4. Mehta R.H., Roe M.T., Mulgund J., et al. Acute clopidogrel use and outcomes in patients with non-ST-segment elevation acute coronary syndromes undergoing coronary artery bypass surgery. J Am Coll Cardiol 48 (2006) 281-286
5. Berger J.S., Frye C.B., Harshaw Q., Edwards F.H., Steinhubl S.R., and Becker R.C. Impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery. J Am Coll Cardiol 52 (2008) 1693-1701
6. Mehta R.H., Chen A.Y., Pollack C.V., et al. Challenges in predicting the need for coronary artery bypass grafting at presentation in patients with non-ST-segment elevation acute coronary syndromes. Am J Cardiol 98 (2006) 624-627
7. Ebrahimi R., Dyke C., Mehran R., et al. Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol 53 (2009) 1965-1972
8. Price M.J., and Teirstein P.S. Dynamics of platelet functional recovery following a clopidogrel loading dose in healthy volunteers. Am J Cardiol 102 (2008) 790-795
9. Mega J.L., Close S.L., Wiviott S.D., et al. Cytochrome P-450 polymorphisms and response to clopidogrel. N Engl J Med 360 (2009) 354-362
10. Trenk D., Hochholzer W., Fromm M.F., et al. Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents. J Am Coll Cardiol 51 (2008) 1925-1934